HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rebecca Gelman Selected Research
Rebecca Gelman Research Topics
Disease
29
Breast Neoplasms (Breast Cancer)
01/2018 - 01/2002
16
Neoplasms (Cancer)
02/2010 - 02/2002
6
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2014 - 02/2005
3
Brain Neoplasms (Brain Tumor)
12/2011 - 06/2003
2
Fatigue
01/2018 - 05/2004
2
Virus Diseases (Viral Diseases)
11/2015 - 05/2002
2
Central Nervous System Diseases (CNS Diseases)
12/2011 - 06/2003
2
HIV Infections (HIV Infection)
12/2010 - 05/2004
2
Ductal Carcinoma
02/2010 - 05/2004
2
Acquired Immunodeficiency Syndrome (AIDS)
01/2008 - 03/2007
2
Infections
03/2007 - 09/2005
1
Triple Negative Breast Neoplasms
01/2018
1
Fanconi Anemia (Fanconi's Anemia)
01/2016
1
Opportunistic Infections (Opportunistic Infection)
01/2008
1
Anemia
09/2007
1
Cardiotoxicity
09/2007
1
Neutropenia
09/2007
1
Disease Progression
09/2007
1
Hypersensitivity (Allergy)
08/2007
1
Drug Hypersensitivity (Drug Allergy)
08/2007
1
Pathologic Complete Response
02/2007
1
Lymphatic Metastasis
04/2006
1
Multiple Sclerosis
04/2006
1
Dermatitis
02/2006
1
Pneumonia (Pneumonitis)
02/2006
1
Radiation Pneumonitis
02/2006
1
Lung Injury
02/2006
1
Hypoxia (Hypoxemia)
12/2005
1
Leukemia
11/2005
1
Leukocytosis (Pleocytosis)
11/2005
1
Febrile Neutropenia
11/2005
1
Pancreatic Neoplasms (Pancreatic Cancer)
11/2005
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2005
Drug/Important Bio-Agent (IBA)
6
Trastuzumab (Herceptin)
FDA Link
04/2008 - 01/2003
4
Proteins (Proteins, Gene)
FDA Link
01/2016 - 11/2005
4
Vinorelbine (Navelbine)
FDA Link
Generic
12/2008 - 08/2003
4
human ERBB2 protein
IBA
04/2008 - 01/2003
4
Paclitaxel (Taxol)
FDA Link
Generic
08/2007 - 01/2003
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2012 - 01/2003
3
Estrogen Receptors
IBA
01/2010 - 05/2003
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2009 - 12/2005
2
Interleukin-2 (IL2)
IBA
03/2007 - 05/2004
2
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2006 - 01/2003
2
Messenger RNA (mRNA)
IBA
12/2005 - 03/2003
1
ruxolitinib
IBA
01/2018
1
Antibodies
IBA
11/2015
1
Autoantibodies
IBA
11/2015
1
Tamoxifen
FDA Link
Generic
01/2014
1
Methotrexate (Mexate)
FDA Link
Generic
11/2012
1
vandetanib (ZD6474)
IBA
11/2012
1
sagopilone
IBA
12/2011
1
epothilone B (EPO906)
IBA
12/2011
1
Dry Ice
IBA
12/2010
1
Nitrogen
IBA
12/2010
1
Vimentin
IBA
02/2010
1
Osteonectin
IBA
02/2010
1
Connexin 43 (Connexin43)
IBA
02/2010
1
Endothelial Protein C Receptor
IBA
02/2010
1
Caveolin 1
IBA
02/2010
1
Keratin-18 (Keratin 18)
IBA
02/2010
1
Phenobarbital (Luminal)
FDA Link
02/2010
1
Claudins
IBA
02/2010
1
Progesterone Receptors (Progesterone Receptor)
IBA
01/2010
1
Celecoxib (Celebrex)
FDA Link
03/2009
1
NF-kappa B (NF-kB)
IBA
03/2009
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
03/2009
1
Prostaglandins
IBA
03/2009
1
Peptide Hydrolases (Proteases)
FDA Link
03/2009
1
Bevacizumab (Avastin)
FDA Link
12/2008
1
Hormones (Hormone)
IBA
12/2008
1
Cathepsin K
IBA
09/2008
1
ErbB Receptors (EGF Receptor)
IBA
04/2008
1
Lapatinib (GW572016)
FDA Link
04/2008
1
taxane
IBA
09/2007
1
Glutamic Acid (Glutamate)
FDA Link
08/2007
1
paclitaxel poliglumex (XYOTAX)
IBA
08/2007
1
rebeccamycin
IBA
04/2007
1
Growth Factor Receptors
IBA
02/2007
1
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
02/2007
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
02/2007
1
Complementary DNA (cDNA)
IBA
04/2006
1
Natalizumab (Tysabri)
FDA Link
04/2006
1
Steroids
IBA
02/2006
1
S100 Calcium Binding Protein A7
IBA
12/2005
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
12/2005
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
11/2005
1
Darbepoetin alfa (Aranesp)
FDA Link
11/2005
1
pegfilgrastim (Neulasta)
FDA Link
11/2005
1
Neoplasm Antigens (Tumor Antigens)
IBA
09/2005
1
Antigens
IBA
09/2005
1
Nucleosides
IBA
05/2004
Therapy/Procedure
14
Therapeutics
11/2012 - 01/2003
11
Drug Therapy (Chemotherapy)
11/2012 - 01/2003
6
Radiotherapy
12/2011 - 01/2002
2
Adjuvant Chemotherapy
04/2007 - 11/2005
2
Segmental Mastectomy (Lumpectomy)
04/2007 - 07/2006
1
Art Therapy
01/2008
1
Highly Active Antiretroviral Therapy (HAART)
03/2007
1
Premedication
11/2005
1
Mastectomy (Mammectomy)
02/2005